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Endothelin regulation by miR-218: A target in scarring
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The adult human dermis scars; scarless repair occurs in the oral
cavity. Alpha-smooth muscle (a-SMA)-expressing myoﬁbroblasts are
resposible for scarring. TGFbeta1 causes myoﬁbroblast differentiation
in dermal but not gingival ﬁbroblasts (N = 3, p&lt0.05). Gingival
ﬁbroblasts express less focal adhesion kinase, display less focal
adhesion kinase phosphorylation and do not induce endothelin-1
(ET-1) in response to TGFbeta1 (N = 3, p&lt0.05). The induction of
ET-1 in response to TGFbeta 1 in dermal ﬁbroblasts does not occur in
the absence of FAK or in the presence of the FAK/src inhibitor PP2
(N = 3, p&lt0.05). Addition of ET-1 to gingival ﬁbroblasts restores
the ability of TGFbeta1 to induce myoﬁbroblast formation (N = 3,
p&lt0.01). Expression proﬁling revealed that, compared to gingival
ﬁbroblasts, dermal ﬁbroblasts overexpress a variety of miRNAs
including miR-218. Addition of miR-218 to gingival ﬁbroblasts
results in enhanced focal adhesion kinase expression and phosphor-
ylation, cell spreading, endothelin-1 production and in the ability of
TGFbeta to induce myoﬁbroblast formation (N-3, p&lt0.01). Knockdown
of miR-218 abolishes the ability of TGFbeta1 to induce myoﬁbroblast
formation in dermal ﬁbroblasts. These results strongly suggest that
the presence or absence of ET-1 is responsible for myoﬁbroblast
formation in ﬁbroblasts. Targeting ET-1 might be a viable approach to
prevent scarring.
doi:10.1016/j.lfs.2013.12.119
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MicroRNAs-1 (miR-1) plays important roles in several biological
processes. ET-1 is upregulated in chronic diabetic complications. In
this study, we investigated the role of miR-1, an ET-1 targeting
miRNA, in the endothelial cells (ECs) and in the organs of diabetic
animals. PCR array was used to identify alteration of miR expressions
in the ECs exposed to glucose. miR-1 expression was validated by
TaqMan Real-Time PCR assay. Human retinal ECs (HRECs) exposed to
various glucose levels with or without miR-1 mimic transfection as
well as tissues from streptozotocin-induced diabetic animals after
2 months of follow-up, were examined for ET-1 mRNA and protein
levels, ﬁbronectin (FN) mRNA and miR-1 expression. Array analyses
showed glucose-induced alterations of 125 miRNAs (out of 381) in
ECs exposed to 25 mM glucose (HG) compared to 5 mM glucose.
Fifty-one miRNAs were upregulated and 74 were downregulated. HG
decreased miR-1 expression and increased ET-1 mRNA and protein
levels. miR-1 mimic transfection prevented HG-induced ET-1
upregulation. Furthermore, glucose induced upregulation of FN,
which is mediated in part by ET-1, was also prevented by such
transfection. Diabetic animals showed decreased miR-1 expression in
the retina, heart, and kidneys. In parallel, ET-1 mRNA expressions
were increased in these tissues of diabetic animals compared to
controls. Furthermore these tissues showed upregulation of FN.
These studies indicate a novel glucose-induced molecular mecha-
nism of tissue damage, in which miR-1 regulates ET-1 expressions in
diabetes. Identifying such mechanisms may lead to potential RNA
based treatment for diabetic complications. Supported by Canadian
Diabetes Assn. and Heart and Stroke Foundation of Canada.
doi:10.1016/j.lfs.2013.12.120
Endothelin-1 mediates downstream proﬁbrotic effects by
transforming growth factor-beta 1 in systemic sclerosis
skin ﬁbroblasts
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Systemic sclerosis (SSc) is an autoimmune connective tissue
disorder characterized by excess collagen deposition and vascular
changes that affect multiple organs. Although transforming growth
factorβ1 (TGF-β1) and endothelin-1 (ET-1) are known to be potent
ﬁbrotic factors in SSc, the relationship between them is not fully
understood. The aim of our study was to examine the effects of TGF-β1
on the ﬁbrogenic phenotype of SSc skin ﬁbroblasts through ET-1
production. Human skin ﬁbroblasts obtained from SSc patients were
incubated with TGF-β1 in the presence of SIS3 (an inhibitor of Smad3
phosphorylation). In addition, the effects of ETRA, ETRB and dual ETRA/
ETRB antagonist were explored. Expression of ET-1, CTGF and type I
collagen was evaluated by using ELISA and real time RT-PCR. ETRA and
ETRB expressions were assessed by immunohistochemistry. We found
that TGF-β1 increased ET-1 mRNA and protein expression and this
increase in ET-1 was suppressed by SIS3. Upregulation of COL1A1 and
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